Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2003
08/06/2003CN1433796A Medicine for treating genital herpes and preparation process thereof
08/06/2003CN1433795A Traditional Chinese granule medicine for preventing and caring prawn viral and bacterial disease
08/06/2003CN1433792A Traditional Chinese medicine for treating child pneumonia
08/06/2003CN1433788A Method for extracting effective active component of rodgersia aesculifolia and use thereof
08/06/2003CN1433785A Formula of adhesive plaster for treating painful swelling
08/06/2003CN1433777A Cerium carried (Ôàó) rectorite anti-inflammatory and bacteriostatic medicine and preparation process thereof
08/06/2003CN1433765A Sodium foscarnet froozen dry preparation and process for preparing same
08/06/2003CN1433764A Sodium foscarnet gel preparation and preparation process thereof
08/06/2003CN1433763A Enoxacin preparation and preparation process thereof
08/06/2003CN1433758A Use of potassium dehydroandrographolide succinate in preparing external used medicine
08/06/2003CN1433757A Use of potassium dehydroandrographolide succinate in preparing oral cavity local applied medicine for treating plaryngitis
08/06/2003CN1433756A Use of potassium dehydroandrographolide succinate in preparing external used medicine for treating dermatosis
08/06/2003CN1117150C EB virus DNA sequences encoding diagnostically releavant virus capid antigen expression clones derived through polymerase chain reaction and use of this recombinant antigen in diagnostic
08/06/2003CN1117149C Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/06/2003CN1117148C Vaccineforinfections agents, compositions for treating and preventing HIV infections
08/06/2003CN1117095C Antibacterial substituted 7-2cylamino-3(methylhydrazono) methyl-cephalosponins and intermediates
08/06/2003CN1117085C Sparfloxacin salt and synthesis method and use thereof
08/06/2003CN1117082C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
08/06/2003CN1116899C Oral pharmaceutical dosage forms comprising a proton pump inhibitorand NSAID
08/06/2003CN1116890C Medicine for treating hepatitis B
08/06/2003CN1116886C Process for preparing Chinese-medicinal pills containing borneol
08/05/2003US6603046 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria.
08/05/2003US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents
08/05/2003US6602999 Preparing a solution of cefpodoxime proxetil in a suitable solvent and recovering amorphous form of cefpodoxime proxetil from said solution by spray drying
08/05/2003US6602991 Solution composed of sodium chloride, monobasic and dibasic sodium phosphate dissolved in water; agitation, filtering and drying; use in the treatment for cholera and as antidote for ferrous ion intoxication
08/05/2003US6602984 Human elastase IV
08/05/2003US6602885 Viricides, organ transplants, antiarthritic agents
08/05/2003US6602882 Quinoline derivatives and their use as antibacterial agents
08/05/2003US6602881 Anti-inflammatory uses of manzamines
08/05/2003US6602879 Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
08/05/2003US6602872 Substituted pyridazines having cytokine inhibitory activity
08/05/2003US6602864 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
08/05/2003US6602709 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
08/05/2003US6602705 Expression of HIV polypeptides and production of virus-like particles
08/05/2003US6602664 3′-azido-2′,3′-dideoxyuridine in an anti-HIV effectiveness test protocol
08/05/2003US6602525 Compositions comprising nitrofurantoin and uva ursi
08/05/2003US6602519 Peptide factor used as replacement to steroid therapy; neutrophil migration stimulating activity; treating conditions associated with an inflammatory response of septic shock
08/05/2003US6602508 Method of immunization using a Group B Streptococcus type II and type III polysaccharide conjugate vaccine
08/05/2003US6602506 Immunogenic composition; bactericidal
08/05/2003US6602505 Polynucleotide comprising caprine arthritis encephalitis virus (CAEV) viral genome renders nonpathogenic to a primate a resulting retroviral particle produced via gene expression, generating immune response against HIV-1
08/05/2003US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions
08/05/2003US6602491 Alkyl hydroxybenzoate in an oral care composition with an alkaline pH
08/05/2003US6602296 Chemical supplementation of bone
08/01/2003CA2370396A1 Hepatitis c inhibitor tri-peptides
08/01/2003CA2369970A1 Hepatitis c inhibitor tri-peptides
07/2003
07/31/2003WO2003062472A1 Cooperative oligonucleotides
07/31/2003WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
07/31/2003WO2003062443A2 Novel substituted alkane compounds and uses thereof
07/31/2003WO2003062424A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof
07/31/2003WO2003062406A1 Method for the production of resveratrol in cell cultures
07/31/2003WO2003062394A2 Methods and compositions for rna interference
07/31/2003WO2003062276A2 Multimers of receptor-binding ligands
07/31/2003WO2003062275A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003WO2003062271A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
07/31/2003WO2003062265A2 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
07/31/2003WO2003062262A2 Modulation of heat-shock-protein-based immunotherapies
07/31/2003WO2003062260A1 Triterpene quaternary salts as biologically active surfactants
07/31/2003WO2003062252A1 Edg receptor agonists
07/31/2003WO2003062242A1 Biocidal compounds and their preparation
07/31/2003WO2003062238A1 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors
07/31/2003WO2003062236A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES
07/31/2003WO2003062231A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones
07/31/2003WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
07/31/2003WO2003062211A1 Pyrimidinone viral polymerase inhibitors
07/31/2003WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
07/31/2003WO2003062204A1 Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
07/31/2003WO2003061767A1 Methods and compositions for the treatment of asthma and related disorders
07/31/2003WO2003061707A1 Dermatological water-resistant compositions with sun screens and method for production and use of such compositions
07/31/2003WO2003061704A2 Combination therapy for the treatment of bacterial infections
07/31/2003WO2003061672A1 Method of treatment of gastrointestinal disease and polymeric composition for use therein
07/31/2003WO2003061671A1 Amido macrolides
07/31/2003WO2003061668A1 Use of pulmonary surfactant for the prevention of infectious diseases
07/31/2003WO2003061667A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies
07/31/2003WO2003061666A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases
07/31/2003WO2003061659A1 Treating stress response with chemokine receptor ccr5 modulators
07/31/2003WO2003061634A1 Sustained release pharmaceutical composition
07/31/2003WO2003061626A1 Polymeric gel system for the controlled delivery of codrugs
07/31/2003WO2003061620A2 Peptide-carrying bodies for immune response
07/31/2003WO2003061589A2 Methods for treating diseases or conditions with peptide constructs
07/31/2003WO2003061577A2 Polyalkylene glycol with moiety for conjugating biologically active compound
07/31/2003WO2003061560A2 Replication competent dual-ad vectors for vaccine and immunotherapy applications
07/31/2003WO2003061558A2 Glycoconjugate vaccines for use in immune-compromised populations
07/31/2003WO2003061554A2 Composition containing moutan root bark extract as active ingredient
07/31/2003WO2003061389A1 Antiseptic compositions and methods
07/31/2003WO2003047516A3 Pyrimidine compounds
07/31/2003WO2003035679A3 Molecules
07/31/2003WO2003034988A3 Injectable compositions for the controlled delivery of pharmacologically active compound
07/31/2003WO2003032911A3 Anti-angiogenic and cytotoxic fused pyrimidines
07/31/2003WO2003029484A3 Antimicrobial methods and materials
07/31/2003WO2003016333A3 Virus coat protein/receptor chimeras and methods of use
07/31/2003WO2003007995A3 Pharmaceutical preparations containing ion exchange resins charged with fluoroquinolone
07/31/2003WO2003006495A3 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket
07/31/2003WO2003000024A3 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
07/31/2003WO2002100408A3 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
07/31/2003WO2002064627A3 Crystallization of igf-1
07/31/2003WO2002060936A3 Vaccine and compositions for the prevention and treatment of neisserial infections
07/31/2003WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
07/31/2003WO2002059148A3 A method for identification, isolation and production of antigens to a specific pathogen
07/31/2003WO2002047730A3 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins
07/31/2003WO2002036203A3 Azole containing compositions with enhanced antifungal activity